Black Diamond Therapeutics Inc
For the period ended Dec 31, 2024. Filed Mar 6, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 6, 2025
BDTX$1.86+7.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except share and per share data)
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $36,437 | $56,221 |
| Investments | 62,138 | 75,179 |
| Prepaid expenses and other current assets | 2,601 | 2,634 |
| Total current assets | 101,176 | 134,034 |
| Property and equipment, net | 1,387 | 1,730 |
| Restricted cash | 819 | 823 |
| Right-of-use assets | 19,009 | 21,980 |
| Other non-current assets | 249 | — |
| Total assets | $122,640 | $158,567 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $4,007 | $2,324 |
| Accrued expenses and other current liabilities | 16,566 | 17,322 |
| Total current liabilities | 20,573 | 19,646 |
| Non-current operating lease liability | 18,782 | 22,185 |
| Total liabilities | 39,355 | 41,831 |
| Commitments and contingencies (Note 12) | — | — |
| Stockholders' equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares and 10,000,000 shares authorized at December 31, 2024 and 2023, respectively; no shares issued or outstanding at December 31, 2024 and 2023 | — | — |
| Common stock; $0.0001 par value; 500,000,000 shares authorized at December 31, 2024 and 500,000,000 shares authorized at December 31, 2023; 56,644,655 shares issued and outstanding at December 31, 2024 and 51,645,557 shares issued and outstanding at December 31, 2023 | 7 | 7 |
| Additional paid-in capital | 570,361 | 534,187 |
| Accumulated other comprehensive income (loss) | 24 | (27) |
| Accumulated deficit | (487,107) | (417,431) |
| Total stockholders' equity | 83,285 | 116,736 |
| Total liabilities and stockholders' equity | $122,640 | $158,567 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.